In the Physiome Project, integrative physiological function is described by computational modeling [1] . The project was motivated by the current wealth of biological data, especially by data from the molecular and cellular levels that are based, in part, on improved instrumentation such as nuclear magnetic resonsance and confocal microscopy. Improved imaging modalites such as MRI and CT, along with other types of
instrumentation, are also producing data at higher levels of biology.
Various workshops and panel recommendations have recognized and addressed the importance in interpreting experimental multiscale results. The Multiscale Modeling Consortium, in conjunction with the Interagency Modeling and Analysis Group (comprised of members of several federal agencies), aim to promote the development and exchange of tools, models, data and standards for the multi-scale modeling community [2] . These goals also represent a major part of the mission of the Physiome Project [1] . Recently, the NSF blue ribbon panel recognized that simulation-based engineering science, [3] applied to the multiscale study of simulation based medicine, may lead further toward the realization of predictive, preventative, personalized, and participatory medicine [2] .
During the last few decades, tremendous progress has been made in computer power, diagnostic and therapeutic medical technologies, and the knowledge of pathophysiology from gene to organ systems. When these advances are combined with efforts to create online databases and tools to share this knowledge, it is increasingly feasible to apply multiscale patient-specific modeling based on proven disease mechanisms to guide and predict the response to therapy in many aspects of medicine. This is an exciting and relatively new approach. These models will provide a better understanding of human physiology and, most importantly, will allow for predictive capabilities of surgery and therapy. This article provides a brief overview of recent accomplishments. The requirements for accurate predictive patient-specific models are outlined.
A patient-specific heart model for cardiac resynchronization therapy is described, briefly.
Computational modeling
A mathematical model is a description of a system in mathematical form; models are used extensively in physics and biophysics. For many such models, it is impossible to find an analytical mathematical solution. Computers can be used to obtain approximate solutions, numerically, and they are therefore usually referred to as computational models. Typically, it takes more computational effort to solve a PDE than it does to solve for an ODE, because of the diversity in possible solutions.
Probably one of the best-known computational tools for solving PDEs is the finite element method. This method was mainly developed in the 1950s, to address the needs for methods in designing complex structures in civil engineering.
The method is suitable for solving PDEs on complex domains, like the blood flow in the aorta, or a deformation in the heart. In the finite element method, a continuous domain is discretized into elements and nodes; the solution is approximated on the domain by linear or higher order functions, which are defined in the elements. For a basic explanation of the finite element method and its application in surgery, see Hashim and Richens (2006) [6] . For an in-depth explanation of the finite element method, see for example Bathe (1996) [7] .
Because computational models quantify physiology mathematically, they also define working hypotheses that are testable, reproducible, and have already been used to improve our understanding of physiologic systems and disease [8] . In the cardiovascular system, computational models have been used to develop subsequently validated hypotheses on the role of repolarization dynamics in initiating life-threatening [9] as well as benign [9] rhythm disturbances. Furthermore, models have provided important insights into the electrophysiologic effects of defibrillation [10] [11] [12] and information about the electrical and mechanical impact of pacing normal [13] [14] [15] and failing [16] [17] [18] hearts ( Fig. 1 ). Because detailed information on the ion channel kinetics of individual myocytes is now available [19] , computational models can also suggest the cellular mechanisms underlying these disease states [20] .
In the clinical arena, computational modeling has provided diagnostic indices [21, 22] , virtual surgery training platforms [23] [24] [25] [26] , and assessments of the effects of surgery [27] [28] [29] [30] .
Multiscale modeling
The need to model at multiple levels, both However, designing a multiscale model that encompasses all biophysical detail on all levels is an impossible task because of the enormous human effort and computer power required. Nonetheless, such a model would not be very useful because a model is a representation of reality designed to help people better understand that reality; a model should be focused on solving a specific problem. For a patient-specific model, efforts should be directed at the pathology in question.
A highly detailed physiologic model demands high computational effort. To reduce computational load, Crampin and colleagues [31] , as well as Bassingthwaighte and colleagues [8] , have acknowledged and addressed the need for simplified models at particular physiologic levels. Taking into account the tradeoff between physiologicand thus, computational-complexity of the model and accuracy of the results, Bassingthwaighte and colleagues [8] proposed a strategy for the design of a multiscale model of physiologic systems. This strategy involves a six-step approach to design and validation of an initial high-resolution multiscale model. Specific components will be simplified in order to gain computational speed, but these simplified components will be kept within a specific valid range. If it is necessary, then inadequate components will be replaced by more detailed ones. The resultant multiscale model will then be validated again.
Mechanistic patient-specific modeling

Significance
The results of randomized clinical trials might not apply directly to individual patients, not even to those who participated in the trial [32] . Important differences exist between individuals in respective treatment groups; these differences can dramatically impact the likelihood of an individual benefiting from a specific therapy. Averaging the effects across different patients can give misleading results about the prospective treatment of an individual whose characteristics likely differ from the mean of a population. This problem is especially highlighted in children, where variability in dimensions is much greater than in adults [33, 34] .
Patient-specific regression models have been successful in identifying patients that would most likely benefit from a certain therapy [35, 36] . However, one drawback of these types of models is that they may not provide much insight into pathophysiologic mechanisms in any specific individual. Modeling mechanistically from a biophysical base would not only provide predictions of certain therapies or surgical interventions, but also the modeling would also provide insight into the success (or failure) of these therapies and interventions.
Many important biophysical properties cannot be measured directly in patients although they can be quantitatively modeled. For example, stress (ie, force per unit area) cannot be measured accurately without damaging tissue. Assuming that stress is a key factor for a specific pathology, information on the dynamics and distribution of biophysical stress may shed light on: (1) cardiac mechanics because stress is closely related to cardiac oxygen consumption [37] ; (2) the mechanics and likelihood of tissue rupture in vascular aneurysms [38] [39] [40] , if stress exceeds a certain threshold; and (3) potential stimuli for growth and remodeling in soft tissues [41] [42] [43] and bone [44] .
Requirements
Initial considerations for modeling should be focused on clinically relevant parameters. There could be more than one parameter used; for example, in the heart, cardiac output is an important measured parameter, yet cardiac output may remain normal due to compensatory mechanisms that mask the disease state [45] . In this way, cardiac output may be normal despite Hounsfield units (a quantitative scale of radiodensity) by CT imaging [49, 50] . For patientspecific cardiac models, methods have been proposed to estimate passive and contractile properties from tagged MR images [30, 40, 51, 52] and cavity pressure measurements. With regard to the latter, methods aimed at deriving end-diastolic and end-systolic pressure-volume relations from single beats [53, 54] can also be helpful in estimating material properties from these relations [30, 40] , but these methods should always be used in combination with data on regional shortening [55] .
Because it is impossible to obtain all possible input parameters for each patient, existing data can be used for completion. For the patientspecific heart model previously described, cardiac fiber architecture will be obtained from the Johns Hopkins University's online datasets (http://www. ccbm.jhu.edu/research/dSets.php) and morphed into the patient-specific cardiac geometries, using the original data on a "host-mesh" [56] . Efforts to create more online databases and tools on biological organization, which is one of the goals of the Physiome Project [57] , will help in this matter.
Another possibility is to estimate parameter values with adaptation algorithms, for example, for bone density [44] , cardiac fiber architecture [58] , or circulation resistance [59] . A potential problem with these algorithms is that biological adaptation, on which the algorithms are based, might be part of the pathology: for example, in the case of cardiac fiber architecture, genetic defects can lead to fiber disarray [60] . Such a fiber-related pathology may render the adaptation algorithm to fall outside the range of validity.
Prediction
The next logical step in using a patient-specific model is to predict, and if necessary, optimize, outcomes from therapy or surgical interventions by applying appropriate interventions. These model interventions can be exactly the same as the intervention to be performed in reality, or to apply the effects, if known, of a particular intervention in a model. In cardiac surgery, an example of the former is to remove tissue in a cardiac ventricular model, exactly as performed in ventricular reduction surgery (ie, the Batista procedure) [28] . To study prostate thermal therapy, one may model acoustic signals to assess pelvic bone heating in the thermal ablation of the prostate [61] . An example of modeling intervention effects indirectly is constraining the motion of myocardium at two opposite regions in the left ventricle to investigate the influence of a myosplint on cardiac function and wall stress, without the need of having to model the physical contact between t-he myosplint and myocardium [29] .
Predictions of the patient-specific models and clinical follow-up are not congruent, several possibilities must be considered. First, components of the patient-specific model may be oversimplified. If so, these inadequate components should be replaced with more detailed models [8] that may require additional measurements. Second, the model may be based on an incomplete pathophysiologic understanding of the disease; additional theoretical or experimental studies may be needed to adequately revise the model.
For example, a model prediction may fail due to biological adaptation, especially in the longterm. Most existing models of interventions to patient-specific models are used to study acute output parameters, and they do not consider longer-term physiologic adaptation. Although acute parameters may accurately predict longterm outcome, the implementation of adaptation algorithms may enhance the predictive capabilities of patient-specific models after an intervention [41, 43, 44, 59, 62, 63] .
Examples of patient-specific modeling
Investigators have been working on the design of patient-specific models in almost all areas of human physiology, at many spatial levels including that of bone structures [56, [63] [64] [65] [66] , skeletal muscle [67] , brain [68, 69] , eye [70] , tongue [71] , teeth [72] , lungs [73] , heart [33, 51, 74] , large arteries [38, 39, 75, 76] , and digestive system [77, 78] . Modeled physics include electrophysiology, solid mechanics, fluid dynamics (gas and fluid), chemistry, thermal dynamics, and combinations of these. Efforts are also being made to model specific pathologies like cancer on the subcellular [79, 80] and tissue levels [68, 81] .
Patient-specific modeling of dilated cardiomyopathy and CRT
The most significant recent advance in management of heart failure (HF) with a conduction block has come from CRT [82, 83] and defibrillator [84] therapy. However, as many as 30% of currently eligible patients fail to respond to CRT. Notably, exact estimation of the percentage of non-responders and enumeration of factors predicting non-response are difficult because of the varying criteria used to define "response." These criteria include: improvements in the distance walked in 6 minutes in the peak oxygen utilization (VO2 max) during exercise; and a decrease in left ventricular end-systolic volume (indicating that cardiac dilatation is reversing). Although these factors make it difficult to select optimal patients for CRT, optimal selection remains of paramount importance to reduce unnecessary implants, procedural risks, and health care expenses.
Because computational models of cardiac electromechanics are currently able to predict the effects of ventricular pacing on regional wall mechanics and global function [18, 85, 86] , the authors of this article propose to develop new computational tools for optimally selecting patients for CRT and for optimizing CRT to each individual patient. Having acquired Institutional Review Board approval, two to five patients with New York Heart Association (NYHA) class III or IV will be recruited at the San Diego VA Medical Center. Implementing the strategy outlined above, investigators will develop patientspecific computational models of the human heart from detailed mapping and test the models' ability to predict observed short-term functional improvements after CRT. The clinical procedures that will be performed include: cardiac contrast CT to obtain ventricular geometry; electroanatomic mapping of both ventricles to obtain ventricular activation patterns during native (dyssynchronous) ventricular activation and during CRT; cardiac ultrasound to obtain dynamic ventricular (ie, pseudo-) volumes; and invasive dynamic pressure measurements during cardiac catheterization. Pressure-volume loops will be obtained during maneuvers to alter pre-load and afterload. Three and six month follow-ups will be performed to assess the long-term outcomes, to determine the predictive accuracy of our models, and also, to provide an opportunity for the patient-specific models to optimize CRT in a patient-tailored fashion.
In summary, efforts are being put in place to develop efficient methods and computational tools for the design of mechanistic multiscale patientspecific models on many levels of physiology. Combined with the abundance of physiological data, these models will be useful on a large scale in the clinic to predict outcomes of surgeries and therapies.
